recall
saveGlenmark Pharmaceuticals Inc., USA recall (Cls II)
community read0 votes
Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg, 3 Blisters each containing 28 Tablets, Rx only, 28 day Regimen, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA., Mahwah, NJ, 07430, NDC 68462-318-29. — Reason: Failed Impurities/Degradation Specifications — Status: Ongoing
view source ↗Data sources
last refreshed just now
Found something off?
same company · ±60 days · 6
- approvalENOBY: ENOBY (DENOSUMAB-QBDE) — FDA approvalOct 29, 2025
- recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Oct 8, 2025
- recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Oct 8, 2025
- recallGranules Pharmaceuticals Inc. recall (Cls III)Oct 1, 2025
- recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Nov 12, 2025
- recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Nov 12, 2025
comments(0)
5-min edit window · permanent after that